Journal of Clinical Medicine, Volume 11, Issue 13
2022 July-1 - 360 articles
Cover Story: This meta-analysis was conducted to assess the association between recipients of pneumococcal vaccine (PV) with mortality and cardiovascular (CV) outcomes among patients with and without established CV disease. A total of 347,444 patients were included: 111,784 patients received PV, and 235,660 patients were in the unvaccinated group. Recipients of PV were associated with decreased all-cause mortality (HR, 0.76 (95% CI: 0.66 to 0.87), p < 0.001), decrease in the incidence of myocardial infarction (MI) (HR, 0.73 (95% CI: 0.56–0.96), p = 0.02), but without significant reduction in CV mortality (HR, 0.87 (95% CI: 0.72–1.07), p = 0.18), and stroke (HR, 1.01 (95% CI: 0.93–1.10), p = 0.82). These findings suggest PV was associated with the decreased risk of all-cause mortality and MI. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.